Largest health care biotech companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 21 health care biotech companies ranked by revenue, at CZK 818.1B, ahead of Gilead Sciences (CZK 655.4B) and Biogen (CZK 220.2B). Figures as of 20 Nov 2026, 12:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 21
- First
- AmgenCZK 818.1B
- Median
- CZK 27B
- Combined market value
- CZK 18.44T
- Countries
- 5
- Not ranked
- 3no revenue on file
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | CZK 818.1B | CZK 5.28T | CZK 9,768.22 | 1.14% down | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | CZK 655.4B | CZK 4.6T | CZK 3,706.99 | 1.45% down | 31% up | ||
| 3 | BiogenBIIB · Health Care | CZK 220.2B | CZK 813.2B | CZK 5,501.16 | 1.70% down | 41% up | ||
| 4 | argenxARGX · Health Care | CZK 92.4B | CZK 1.32T | CZK 20,970.00 | 0.08% up | 3% up | ||
| 5 | BioNTechBNTX · Health Care | CZK 70.9B | CZK 449.1B | CZK 1,811.54 | 2.26% down | 15% down | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | CZK 63.7B | CZK 352.8B | CZK 3,485.72 | 3.85% down | 10% up | ||
| 7 | ExelixisEXEL · Health Care | CZK 51.6B | CZK 357.6B | CZK 1,465.39 | 3.60% down | 55% up | ||
| 8 | QiagenQGEN · Health Care | CZK 46.5B | CZK 228.1B | CZK 1,104.77 | 0.14% up | 6% up | ||
| 9 | ModernaMRNA · Health Care | CZK 43.3B | CZK 1.8T | CZK 4,437.13 | 1.29% up | 740% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | CZK 31.1B | CZK 236.1B | CZK 2,071.09 | 2.88% down | 32% up | ||
| 11 | Bio-TechneTECH · Health Care | CZK 27B | CZK 254.2B | CZK 1,618.32 | 0.07% down | 18% up | ||
| 12 | RepligenRGEN · Health Care | CZK 16.4B | CZK 242.3B | CZK 3,790.69 | 1.38% down | 5% up | ||
| 13 | Krystal BiotechKRYS · Health Care | CZK 8.7B | CZK 208.3B | CZK 7,030.22 | 0.15% up | 49% up | ||
| 14 | Twist BioscienceTWST · Health Care | CZK 8.4B | CZK 169.4B | CZK 2,484.68 | 4.07% down | 291% up | ||
| 15 | Adaptive BiotechnologiesADPT · Health Care | CZK 6.2B | CZK 101.1B | CZK 624.40 | 1.44% down | 51% up | ||
| 16 | ImmunityBioIBRX · Health Care | CZK 2.5B | CZK 155.6B | CZK 146.25 | 1.94% down | 216% up | ||
| 17 | Kymera TherapeuticsKYMR · Health Care | CZK 872.8M | CZK 226.9B | CZK 2,657.65 | 1.44% down | 81% up | ||
| 18 | CG OncologyCGON · Health Care | CZK 89.9M | CZK 162.8B | CZK 1,823.11 | 2.38% up | 93% up | ||
| 19 | CRISPR TherapeuticsCRSP · Health Care | CZK 78.1M | CZK 84.1B | CZK 866.59 | 3.14% down | 22% down | ||
| 20 | Revolution MedicinesRVMD · Health Care | CZK 0 | CZK 767.6B | CZK 3,548.94 | 0.24% down | 125% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | CZK 0 | CZK 136.8B | CZK 1,121.25 | 4.94% up | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2602 CZK). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care biotech companies rank first by revenue?
Amgen (CZK 818.1B), Gilead Sciences (CZK 655.4B) and Biogen (CZK 220.2B) are the top three of the 21 health care biotech companies ranked by revenue as of 20 Nov 2026, 12:56 UTC.
How many health care biotech companies are in this ranking?
21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these health care biotech companies worth together?
The 21 health care biotech companies ranked by revenue have a combined market value of CZK 18.44T as of 20 Nov 2026, 12:56 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care biotech companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.